Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  McKesson Corporation    MCK

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

McKesson Corporation : McKesson wins new two-year Veterans Affairs contract

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/12/2012 | 01:02am CEST

Pharmaceutical wholesaler McKesson Corp on Wednesday said it was selected by the U.S. Department of Veterans Affairs to continue as the VA's prime pharmaceutical supplier for at least two more years.

News of the contract, which includes options for up to three two-year extensions, sent shares of McKesson up more than 4 percent in after hours trading.

The new agreement, valued by the VA at over $31.6 billion, calls for McKesson to supply all of the VA's more than 700 medical centers and outpatient clinics, as well as its seven consolidated mail outpatient pharmacies.

"Over the past eight years, McKesson has partnered with the VA to serve the healthcare needs of America's veterans," Paul Julian, the company's executive vice president and group president, said in a statement.

The VA, which estimated savings of about $3.26 billion through the life of the contract, said the new agreement goes into effect on May 10.

Shares of McKesson, which closed at $87.90 on the New York Stock Exchange, were trading at $91.89 after hours.

(Reporting By Deena Beasley, editing by M.D. Golan)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MCKESSON CORPORATION
10/18 MCKESSON CORPORATION : to Present at 26th Annual Credit Suisse Healthcare Confer..
10/18 MCKESSON : RxOwnership Expands Support of Independent Pharmacy Ownership
10/17 MCKESSON CORPORATION : to Present at the 26th Annual Credit Suisse Healthcare Co..
10/17 MCKESSON : Commits $100,000 to the American Red Cross to Support California Wild..
10/16 MCKESSON : How Hospital Pharmacies Can Optimize Patient Assistance Programs
10/14 Opioid lawsuit expanded to include manufacturers
10/14 MCKESSON : Commits $100,000 to American Red Cross to Support California Wildfire..
10/14 MCKESSON : Commits $100,000 to the American Red Cross to Support California Wild..
10/11 MCKESSON : VERZENIO (abemaciclib) Approved for Treatment of Metastatic Breast Ca..
10/09 MCKESSON : Community Oncology Practices as Clinical Trial Partners
More news
News from SeekingAlpha
10/17 Profit From The Elephant In The Room
10/13 60 Minutes report-stocked selloff in drug distributors overblown - Cowen
10/13 60 Minutes to run piece on opioid epidemic critical of suppliers this Sunday;..
10/12 The Lower Volatility Stock Portfolio For Retirees And Others
10/10 Premarket analyst action - healthcare
Financials ($)
Sales 2018 206 B
EBIT 2018 3 700 M
Net income 2018 1 875 M
Debt 2018 3 058 M
Yield 2018 0,82%
P/E ratio 2018 16,73
P/E ratio 2019 15,03
EV / Sales 2018 0,16x
EV / Sales 2019 0,16x
Capitalization 30 784 M
Chart MCKESSON CORPORATION
Duration : Period :
McKesson Corporation Technical Analysis Chart | MCK | US58155Q1031 | 4-Traders
Technical analysis trends MCKESSON CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 14
Average target price 171 $
Spread / Average Target 17%
EPS Revisions
Managers
NameTitle
John H. Hammergren Chairman, President & Chief Executive Officer
James A. Beer Chief Financial Officer & Executive Vice President
Kathleen D. McElligott Chief Technology & Information Officer, EVP
M. Christine Jacobs Independent Director
Marie L. Knowles Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MCKESSON CORPORATION4.10%30 784
CVS HEALTH-8.20%73 833
WALGREENS BOOTS ALLIANCE-18.37%72 125
EXPRESS SCRIPTS HOLDING CO-16.94%33 042
CARDINAL HEALTH INC-9.74%20 514
AMERISOURCEBERGEN CORP.1.60%17 518